Heart Failure pp 233-237 | Cite as

Patient Selection, Pretransplant Management, Donor and Recipient Matching

  • David S. FeldmanEmail author
  • Sudha P. Jaganathan
  • Parvathi Mudigonda
Part of the Cardiovascular Medicine book series (CVM)


The prevalence of advanced heart failure (HF) is on the rise and patients today are older, more complex and at higher risk of poor outcomes. Despite advances in evidence-based therapies, or in some instances a result of, there is often progression towards end stage HF. Timely referral to advanced HF specialists is imperative to improve quality of life, and in select patients, prolong life expectancy.

The gold standard of advanced HF treatment remains cardiac transplantation, with a 1-year survival rate approaching 90%. At roughly 12 years, the survival rate is about 50%. Since the first human heart transplant in 1967, survival has drastically improved due to progress in the areas of immunosuppression, infection control and, recipient and donor selection. Transplantation is also associated with improved quality of life and exercise capacity (Crespo-Leiro et al., Eur J Heart Fail., 2018). Regardless of the growing number of advanced heart failure patients, there still remains a shortage of donor hearts (Khush et al., Am J Transplant 15(3):642–9, 2015) with around 2500 available annually in the USA over the last two decades and around 3700 available worldwide (Khush et al., Am J Transplant 15(3):642–9, 2015; Ahmet et al., J Thorac Dis 6(8):1097–104, 2014). The relative dearth of available organs combined with increased emphasis on quality and outcomes in organ transplantation make the criteria for appropriate recipient and donor selection and management stringent and paramount in assessing individual institutional outcomes against national mortality and graft survival [1].


  1. 1.
    Ahmet K, et al. Donor selection in heart transplantation. J Thorac Dis. 2014;6(8):1097–104.Google Scholar
  2. 2.
    Crespo-Leiro MG, et al. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018.
  3. 3.
    Mehra MR, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10 year update. J Heart Lung Transplant. 2016;35(1):1–23.CrossRefGoogle Scholar
  4. 4.
    Gardner RS, et al. Who needs a heart transplant? Eur Heart J. 2006;27:770–2.CrossRefGoogle Scholar
  5. 5.
    Fanaroff AC, et al. Patient selection for advanced heart failure therapy referral. Crit Pathw Cardiol. 2014;13(1):1–5.CrossRefGoogle Scholar
  6. 6.
    Alraies CM, Eckman P. Adult heart transplant: indications and outcomes. J Thorac Dis. 2014;6(8):1120–8.PubMedPubMedCentralGoogle Scholar
  7. 7.
    AbouEzzeddine OF, Redfield MM. Who has advanced heart failure? definition and epidemiology. Congest Heart Fail. 2011;17(4):160–8.CrossRefGoogle Scholar
  8. 8.
    de Jonge N, Kirkels JH, et al. Guidelines for heart transplantation. Neth Hear J. 2008;16(3):19–87.Google Scholar
  9. 9.
    Tonsho M, et al. Heart transplantation: challenges facing the field. Cold Spring Harb Perspect Med. 2014;4:a015636.CrossRefGoogle Scholar
  10. 10.
    Costanzo MR, et al. The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29(8):914–56.CrossRefGoogle Scholar
  11. 11.
    Avery RK. Recipient screening prior to solid-organ transplantation. Clin Infect Dis. 2002;35:1513–9.CrossRefGoogle Scholar
  12. 12.
    Kobashigawa J, et al. Report from a consensus conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant. 2009;28(3):213–25.CrossRefGoogle Scholar
  13. 13.
    U.S. Department of Health and Human Services.
  14. 14.
    Hsich EM. Matching the market for heart transplantation. Circ Heart Fail. 2016;9(4):e002679.CrossRefGoogle Scholar
  15. 15.
    Khush KK, et al. National decline in donor heart utilization with regional variability: 1995–2010. Am J Transplant. 2015;15(3):642–9.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • David S. Feldman
    • 1
    Email author
  • Sudha P. Jaganathan
    • 2
  • Parvathi Mudigonda
    • 2
  1. 1.Division of Cardiology, Department of MedicineUniversity of CincinnatiCincinnatiUSA
  2. 2.University of CincinnatiCincinnatiUSA

Personalised recommendations